Published in Eur J Cancer Clin Oncol on June 01, 1987
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer (1991) 0.91
Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Fertil Steril (2012) 0.83
Steroid hormones affect binding of the sigma ligand 11C-SA4503 in tumour cells and tumour-bearing rats. Eur J Nucl Med Mol Imaging (2009) 0.78
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids. Br J Cancer (2004) 0.77
Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer. Breast Cancer (Dove Med Press) (2011) 0.75
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The clinical course of bone metastases from breast cancer. Br J Cancer (1987) 4.93
Blockage of sodium conductance increase in lobster giant axon by tarichatoxin (tetrodotoxin). J Gen Physiol (1966) 4.68
Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet (1991) 4.09
An upper limit to the number of sodium channels in nerve membrane? J Physiol (1967) 3.98
Ionic conductance changes in lobster axon membrane when lanthanum is substituted for calcium. J Gen Physiol (1966) 3.83
Assessment of response to therapy in advanced breast cancer. Br J Cancer (1977) 3.70
Stress and relapse of breast cancer. BMJ (1989) 3.07
Basis of tetrodotoxin's selectivity in blockage of squid axons. J Gen Physiol (1967) 2.97
Comparison of tetrodotoxin and procaine in internally perfused squid giant axons. J Gen Physiol (1967) 2.90
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. J Clin Oncol (1998) 2.73
Tetrodotoxin's highly selective blockage of an ionic channel. Fed Proc (1968) 2.68
Alkali cation selectivity of squid axon membrane. Ann N Y Acad Sci (1966) 2.40
Reconstitution of interleukin 2 with albumin for infusion. Lancet (1990) 2.37
Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28
Who needs steroid receptor assays? Lancet (1989) 2.27
Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg (1989) 2.23
Tetrodotoxin does not block excitation from inside the nerve membrane. Science (1966) 2.22
Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20
Spatial regulation of a zebrafish patched homologue reflects the roles of sonic hedgehog and protein kinase A in neural tube and somite patterning. Development (1996) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol (1990) 1.94
Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization. Am J Cardiol (1992) 1.93
Simulations of conduction in uniform myelinated fibers. Relative sensitivity to changes in nodal and internodal parameters. Biophys J (1978) 1.85
Axon voltage-clamp simulations. I. Methods and tests. Biophys J (1975) 1.77
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
A kinetic model for the sodium conductance system in squid axon. Biophys J (1976) 1.74
Oestrogen receptors and the response to endocrine therapy in advanced breast cancer. Br J Cancer (1978) 1.71
On numerical integration of the Hodgkin and Huxley equations for a membrane action potential. J Theor Biol (1974) 1.70
Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer (1996) 1.70
Axon voltage-clamp simulations. A multicellular preparation. Biophys J (1975) 1.69
Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer (1993) 1.68
Bone metastases and breast cancer. Cancer Treat Rev (1985) 1.67
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res (2000) 1.60
A DEMONSTRATION OF TREPONEMA PALLIDUM IN THE BRAIN IN CASES OF GENERAL PARALYSIS. J Exp Med (1913) 1.56
Condylactis toxin: interaction with nerve membrane ionic conductances. Science (1969) 1.55
Nimesulide, a COX-2 inhibitor, does not reduce lesion size or number in a nude mouse model of endometriosis. Hum Reprod (2004) 1.55
Transcatheter embolisation to control severe bleeding in fungating breast cancer. Eur J Surg Oncol (1988) 1.53
Conduction velocity and spike configuration in myelinated fibres: computed dependence on internode distance. J Neurol Neurosurg Psychiatry (1977) 1.52
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy (2000) 1.50
Tetrodotoxin derivatives: chemical structure and blockage of nerve membrane conductance. Science (1967) 1.49
A genomic timescale for the origin of eukaryotes. BMC Evol Biol (2001) 1.49
Advanced breast cancer: use of resources and cost implications. Br J Cancer (1993) 1.48
Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme. Eur J Cancer (2003) 1.47
Propagation of action potentials in inhomogeneous axon regions. Fed Proc (1975) 1.46
A prospective study of plasma prolactin levels and subsequent risk of breast cancer. Int J Cancer (1981) 1.46
Chemotherapy of advanced breast cancer: outcome and prognostic factors. Br J Cancer (1993) 1.45
Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med (1988) 1.44
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer (1987) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Morbidity and mortality following laparoscopic-assisted right hemicolectomy for cancer. Dis Colon Rectum (1996) 1.42
Axons regulate Schwann cell expression of the POU transcription factor SCIP. J Neurosci (1994) 1.42
Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer. Eur J Cancer Clin Oncol (1983) 1.42
Temperature-sensitive conduction failure at axon branch points. J Neurophysiol (1978) 1.41
Latent inhibition and stimulus generalization of the classically conditioned nictitating membrane response in rabbits (Oryctolagus cuniculus) following dorsal hippocampal ablation. J Comp Physiol Psychol (1975) 1.40
Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur J Cancer (1981) 1.36
Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer (1994) 1.35
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808). Eur J Cancer (1991) 1.35
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
Profile of cognitive progression in early Huntington's disease. Neurology (2003) 1.35
Flow and fracture in drying nanoparticle suspensions. Phys Rev Lett (2003) 1.33
A numerical method to model excitable cells. Biophys J (1978) 1.32
alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene (1999) 1.31
A new combined approach to the conservative treatment of early breast cancer. Surgery (1984) 1.30
Identification of ionic currents at presynaptic nerve endings of the lizard. J Physiol (1989) 1.30
Congenital unilateral pulmonary venous atresia: definitive diagnosis and treatment. Pediatr Cardiol (2002) 1.30
Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet (1986) 1.30
Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer (1990) 1.29
Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood (1987) 1.27
Risk of complications from bone metastases in breast cancer. implications for management. Eur J Cancer (2000) 1.26
Synaptic current at the squid giant synapse. Science (1969) 1.26
A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br J Cancer (1997) 1.26
Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet (1985) 1.26
A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer (1997) 1.25
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Nonlinear cable equations for axons. I. Computations and experiments with internal current injection. J Gen Physiol (1979) 1.24
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Relationship between plasma carcinoembryonic antigen and prognosis in women with breast cancer. Eur J Cancer (1975) 1.24
Aortopulmonary collateral vessels and prolonged pleural effusions after modified Fontan procedures. Am Heart J (1996) 1.23
Dynamics of intracellular calcium and its possible relationship to phasic transmitter release and facilitation at the frog neuromuscular junction. J Neurosci (1984) 1.23
Mastectomy or conservation for early breast cancer: psychological morbidity. Eur J Cancer (1992) 1.22
Prognosis in inoperable stage III carcinoma of the breast. Eur J Cancer (1977) 1.22
DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer (1990) 1.21
Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors. Eur J Cancer (1993) 1.21
Potassium ion currents in the crayfish giant axon. Dynamic characteristics. Biophys J (1981) 1.21
Weekly epirubicin for breast cancer with liver metastases and abnormal liver biochemistry. Br J Cancer (1989) 1.21
On the site of impulse initiation in a neurone. J Physiol (1983) 1.20
Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron (1992) 1.18
Controlled trial of adjuvant chemotherapy with cyclophosphamide, methotrexate, and fluorouracil for breast cancer. Lancet (1984) 1.18
Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Br J Cancer (1988) 1.18
Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives. J Antibiot (Tokyo) (1977) 1.17
Cigarette smoking and steroid hormones in women. J Steroid Biochem Mol Biol (1991) 1.16